Thu Dec 26 21:02:37 UTC 2024: **Senores Pharmaceuticals IPO Oversubscribed, Allotment Today, Listing Monday**

MUMBAI, INDIA – December 26, 2024 – Senores Pharmaceuticals Ltd.’s initial public offering (IPO), which closed on Tuesday, has been massively oversubscribed, receiving a total subscription of 97.86 times. The IPO, priced between Rs 372 and Rs 391 per share, saw strong interest across all categories: retail investors subscribed 93.16 times, non-institutional investors 100.35 times, and qualified institutional buyers 97.84 times.

The allotment of shares will be finalized this evening. Investors can check their allotment status online via the BSE website (https://www.bseindia.com/investors/appli_check.aspx), the NSE website, or the Link Intime registrar portal (https://www.linkintime.co.in/Initial_Offer/public-issues.html). Successful applicants will also receive a bank debit message.

The IPO, a combination of a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore, raised nearly Rs 261 crore from anchor investors. Proceeds will be used for various purposes, including setting up a new manufacturing facility and funding working capital.

Trading in the grey market indicates a strong market sentiment, with unlisted shares currently trading at Rs 631, a 61.38% premium over the IPO price. This suggests a potentially robust listing on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on Monday, December 30. The Ahmedabad-based company specializes in manufacturing complex pharmaceutical products. Equirus Capital, Ambit, and Nuvama Wealth Management acted as book running lead managers for the IPO.

Read More